Eribulin Eg

Eribulin is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin is primarily used in the treatment of metastatic breast cancer. It is administered intravenously and is often considered when other treatments have not been effective. The medication targets cancer cells to inhibit their growth and spread. Patients typically discuss with their healthcare provider to determine if Eribulin is suitable for their specific condition.

Common effects of Eribulin may include fatigue, nausea, and hair loss. Some patients may experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects vary among individuals and should be monitored by a healthcare professional.

Eribulin should be handled with care, as it is a potent chemotherapy agent. It is important to follow the healthcare provider's instructions for administration and monitoring. Patients should be aware of potential side effects and report any severe reactions promptly.

Eribulin may interact with other medications, including those that affect liver enzymes. It is important to inform the healthcare provider about all current medications to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may exacerbate certain side effects.